FDA authorizes Regeneron’s Covid treatment, taken by Trump, for emergency use

Published on:

Regeneron’s therapy is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight infections.

Read more    Source: cnbc.com